OncoPath: cervical cancer screening
Validated, scalable cervical cancer screening for underserved populations worldwide, combining PAICON's AI technology with ETICCS' clinical expertise.
We are a Heidelberg-based health AI company building one of the world's most representative clinical datasets, and the infrastructure to turn it into care that reaches every continent.
To build the world's most genetically and technically diverse multimodal health data ecosystem for personalized medicine.
Our mission is to close the data gap that left 84% of the world out of modern medicine. What we gather today decides whose biology tomorrow's AI models, diagnostics and drugs actually work for.
This book, Remaining 84, mapped what exists: the 16% of humanity today's health AI has learned from, and the 84% it has not.
"But what exists is already changing. Human biology was never static, and globalisation has only made that visible faster. The science is chasing a moving target, and that is not the problem. That is the point."
PAICON is how we keep up with it.
All profits from this book are dedicated to NGOs supporting orphaned children worldwide.
Clinicians, ML scientists, data engineers and key advisors drawn from multidisciplinary fields.





Hospital networks, research institutions and clinical partners shape our data, products and standards. Two collaborations are already deployed in the clinic: OncoPath with ETICCS and PaiChat with iPath.
Validated, scalable cervical cancer screening for underserved populations worldwide, combining PAICON's AI technology with ETICCS' clinical expertise.
Instant second opinions and collaborative diagnostics for pathologists worldwide, pairing PaiChat with iPath's global telepathology network.
We work with hospital networks, research institutions and clinical partners across the globe. If you're exploring a joint initiative or collaboration, send us a note.